The amyloid precursor protein (APP) plays a central role in Alzheimer’s disease (AD), as it is processed into different proteolytic products, including the toxic Aβ peptide, accumulating in AD brain tissue. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.